全文获取类型
收费全文 | 1275179篇 |
免费 | 94200篇 |
国内免费 | 1984篇 |
专业分类
耳鼻咽喉 | 18186篇 |
儿科学 | 42257篇 |
妇产科学 | 37816篇 |
基础医学 | 187018篇 |
口腔科学 | 35380篇 |
临床医学 | 108113篇 |
内科学 | 251448篇 |
皮肤病学 | 26498篇 |
神经病学 | 99187篇 |
特种医学 | 49986篇 |
外国民族医学 | 366篇 |
外科学 | 197596篇 |
综合类 | 26513篇 |
现状与发展 | 1篇 |
一般理论 | 300篇 |
预防医学 | 92590篇 |
眼科学 | 29057篇 |
药学 | 97762篇 |
1篇 | |
中国医学 | 2496篇 |
肿瘤学 | 68792篇 |
出版年
2018年 | 11811篇 |
2015年 | 11612篇 |
2014年 | 15997篇 |
2013年 | 24347篇 |
2012年 | 33550篇 |
2011年 | 35941篇 |
2010年 | 21211篇 |
2009年 | 20016篇 |
2008年 | 34978篇 |
2007年 | 37941篇 |
2006年 | 38500篇 |
2005年 | 37799篇 |
2004年 | 36382篇 |
2003年 | 35371篇 |
2002年 | 34917篇 |
2001年 | 58094篇 |
2000年 | 59587篇 |
1999年 | 50691篇 |
1998年 | 14234篇 |
1997年 | 12813篇 |
1996年 | 13072篇 |
1995年 | 12348篇 |
1994年 | 11757篇 |
1993年 | 10861篇 |
1992年 | 40985篇 |
1991年 | 40361篇 |
1990年 | 39891篇 |
1989年 | 38708篇 |
1988年 | 36110篇 |
1987年 | 35351篇 |
1986年 | 33726篇 |
1985年 | 32137篇 |
1984年 | 23926篇 |
1983年 | 20819篇 |
1982年 | 12381篇 |
1981年 | 10928篇 |
1980年 | 10204篇 |
1979年 | 22639篇 |
1978年 | 15880篇 |
1977年 | 13730篇 |
1976年 | 12971篇 |
1975年 | 14201篇 |
1974年 | 16685篇 |
1973年 | 16078篇 |
1972年 | 15318篇 |
1971年 | 14230篇 |
1970年 | 13215篇 |
1969年 | 12731篇 |
1968年 | 11979篇 |
1967年 | 10479篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
Enrique Luengo Izaskun Buendia Cristina Fernndez‐Mendívil Paula Trigo‐Alonso Pilar Negredo Patrycja Michalska Borja Hernndez‐García Cristina Snchez‐Ramos Juan A. Bernal Tsuneya Ikezu Rafael Len Manuela G. Lpez 《Journal of pineal research》2019,67(1)
Alterations in autophagy are increasingly being recognized in the pathogenesis of proteinopathies like Alzheimer's disease (AD). This study was conducted to evaluate whether melatonin treatment could provide beneficial effects in an Alzheimer model related to tauopathy by improving the autophagic flux and, thereby, prevent cognitive decline. The injection of AAV‐hTauP301L viral vectors and treatment/injection with okadaic acid were used to achieve mouse and human ex vivo, and in vivo tau‐related models. Melatonin (10 μmol/L) impeded oxidative stress, tau hyperphosphorylation, and cell death by restoring autophagy flux in the ex vivo models. In the in vivo studies, intracerebroventricular injection of AAV‐hTauP301L increased oxidative stress, neuroinflammation, and tau hyperphosphorylation in the hippocampus 7 days after the injection, without inducing cognitive impairment; however, when animals were maintained for 28 days, cognitive decline was apparent. Interestingly, late melatonin treatment (10 mg/kg), starting once the alterations mentioned above were established (from day 7 to day 28), reduced oxidative stress, neuroinflammation, tau hyperphosphorylation, and caspase‐3 activation; these observations correlated with restoration of the autophagy flux and memory improvement. This study highlights the importance of autophagic dysregulation in tauopathy and how administration of pharmacological doses of melatonin, once tauopathy is initiated, can restore the autophagy flux, reduce proteinopathy, and prevent cognitive decline. We therefore propose exogenous melatonin supplementation or the development of melatonin derivatives to improve autophagy flux for the treatment of proteinopathies like AD. 相似文献
63.
64.
65.
66.
67.
68.
69.
70.
William G. Breen Krishan R. Jethwa Nathan Y. Yu Grant M. Spears William S. Harmsen Robert C. Miller Jonathan B. Ashman William G. Rule Terence T. Sio Michelle A. Neben-Wittich Michael G. Haddock Amit Mahipal Mark J. Truty Christopher L. Hallemeier Kenneth W. Merrell 《Practical radiation oncology》2021,11(1):e63-e69
PurposeOur purpose was to determine the effect of chemoradiotherapy (CRT) on patient-reported quality of life (QOL) for patients with intact pancreas cancer.Methods and MaterialsWe reviewed a prospective QOL registry for patients with intact, clinically localized pancreatic ductal adenocarcinoma treated with CRT between June 2015 and November 2018. QOL was assessed pre-CRT (immediately before CRT, after neoadjuvant chemotherapy) and at the completion of CRT with the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) and its component parts: FACT-General (FACT-G) and hepatobiliary cancer subscore (HCS). A minimally important difference from pre-CRT was defined as ≥ 6, 5, and 8 points for FACT-G, HCS, and FACT-Hep, respectively.ResultsOf 157 patients who underwent CRT, 100 completed both pre- and post-CRT surveys and were included in the primary analysis. Median age at diagnosis was 65 years (range, 23-90). National Comprehensive Cancer Network resectability status was resectable (3%), borderline resectable (40%), or locally advanced (57%). Folinic acid, 5-fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) (75%) or gemcitabine and nab-paclitaxel (42%) were given for a median of 6 cycles (range, 0-42) before CRT. Radiation therapy techniques included 3-dimensional conformal (22%), intensity modulated photon (55%), and intensity modulated proton (23%) radiation therapy to a median dose of 50 Gy (range, 36-62.5). Concurrent chemotherapy was most commonly capecitabine (82%). Sixty-three patients (63%) had surgery after CRT. The mean decline in FACT-G, HCS subscale, and FACT-Hep from pre- to post-CRT was 3.5 (standard deviation [SD], 13.7), 1.7 (SD 7.8), and 5.2 (SD 19.4), respectively. Each of these changes were statistically significant, but did not meet the minimally important difference threshold. Pancreatic head tumor location was associated with decline in FACT-Hep. Nausea was the toxicity with the greatest increase from pre- to post-CRT by both physician-assessment and patient-reported QOL.ConclusionsFor patients with intact pancreatic adenocarcinoma, modern CRT is well tolerated with minimal decline in QOL during treatment. 相似文献